Chinese non-human primates are hitting biomedical research activity in India hard. But stringent guidelines of the Drugs Controller General of India (DCGI) on the use of non-human primates (NHPs) in biomedical research are forcing pharmaceutical companies to head for China and other Asian countries for drug testing.
